Junzo Ishizaki

Nichinan, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Prognostic value of lymphocyte-to-monocyte ratio in relapsed/refractory adult T-cell Leukemia/lymphoma patients receiving mogamulizumab.

Prognostic value of lymphocyte-to-monocyte ratio in relapsed/refractory adult T-cell Leukemia/lymphoma patients receiving mogamulizumab.

Journal: Clinical immunology (Orlando, Fla.)
Published: July 01, 2025

Effects of tucidinostat in adult T-cell leukemia/lymphoma in clinical practice.

Effects of tucidinostat in adult T-cell leukemia/lymphoma in clinical practice.

Journal: International journal of hematology
Published: October 17, 2024

Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan.

Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan.

Journal: International journal of hematology
Published: October 26, 2023

Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers.

Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers.

Journal: BMC infectious diseases
Published: August 28, 2023

Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma.

Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma.

Journal: Viruses
Published: February 28, 2022

Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, Japan.

Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, Japan.

Journal: Journal of clinical medicine
Published: November 04, 2020

Higher average chemotherapy dose intensity improves prognosis in patients with aggressive adult T-cell leukemia/lymphoma.

Higher average chemotherapy dose intensity improves prognosis in patients with aggressive adult T-cell leukemia/lymphoma.

Journal: European journal of haematology
Published: October 15, 2020

Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemia.

Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemia.

Journal: International journal of hematology
Published: May 01, 2018

Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan.

Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan.

Journal: International journal of hematology
Published: December 05, 2017

Effects of mogamulizumab in adult T-cell leukemia/lymphoma in clinical practice.

Effects of mogamulizumab in adult T-cell leukemia/lymphoma in clinical practice.

Journal: European journal of haematology
Published: January 25, 2017

Acute myeloid leukemia in clinical practice: a retrospective population-based cohort study in Miyazaki Prefecture, Japan.

Acute myeloid leukemia in clinical practice: a retrospective population-based cohort study in Miyazaki Prefecture, Japan.

Journal: International journal of hematology
Published: November 14, 2011
Showing 1-11 of 11

Last Updated: 09/26/2026